Our valued members recognize that our Journals provide much needed guidance and regulatory insights for validating and remaining compliant while working in the medical device, pharmaceutical and biotech industries. Whether FDA regulations, EU GMP practices or Japanese GMP guidelines, the resources provided in JVT and GXP publications allow professionals to stay current on existing and emerging regulations, as well as learn from colleagues on best practices and audit expectations. While out journals will continue to provide the best in back-to-basics topics, as well as highlight to newest protocols, we recognize that we are in a time of change that will offer great impact to pharma manufacturing in all aspects. For this reason, we have launched a regular blog series that will provide insight on many emerging topics of interest.
MORE TO OFFER:
We invite you to read the first posts in the series which highlight some of the most watched technologies and processes that our industry professionals are keeping abreast of. In our first posts, Dr. Tim Sandle advises us on the latest trends to impact our industry. Understand how artificial intelligence, machine learning, internet of things, blockchain, predictive analytics and much more will change the way we do business. In the next in the series you can read about blockchain and how it will directly impact healthcare and possibly end the falsification of medicines.
Consecutive posts to follow in a variety of topics involving disruptive technologies, machine learning, data integrity in the face of AI, telemedicine, super generics, and much more.
As technology changes rapidly we look to you, our readers and advisors to educate the growing audience. If you are an expert in any emerging technologies or processes and would like to contribute a blog post, we would welcome your submissions. Please email Stacey Bruzzese, Managing Editor at Stacey.email@example.com